Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, November 2008

Sort by: Newest first Oldest first A-Z Z-A

  • PJ letters (29 November 2008) Subscription

    28 NOV 2008 22:19
    Comments (1)

    Letters on the following topics have been published in the 29 November 2008 issue of The Pharmaceutical Journal.The letters pages are available as a downloadable PDF (60K).

  • Gathering momentum Subscription

    28 NOV 2008 18:53

    It has arrived, on time and in good working order. The prospectus for the new professional body has now been distributed to members and many other interested parties on behalf of the Transitional Committee, and comments on it are invited up until 9 January 2009.

  • Prospectus for new professional body

    Transcom’s vision for the new body

    28 NOV 2008 18:38

    The Transitional Committee has published its prospectus for the new professional body for pharmacy. Debbie Andalo describes its highlights 

  • GPhC: overcoming the iceberg effect Subscription

    28 NOV 2008 18:22

    There is an iceberg effect around the regulation of healthcare professionals: it is the disciplinary activities of regulation which generally excite interest and generate news, yet these concentrate retrospectively on only a small minority of practitioners.

  • APRIL 2008: Adverse Psychiatric Reactions Information Link conference (reports)

    28 NOV 2008 18:08

    Not all healthcare professionals are as informed about side effects as they could be. At a conference on adverse psychiatric reactions the underlying message was that greater awareness, in both healthcare professionals and patients, about drug side effects is needed. Lin-Nam Wang reportsBeware of how side effects are masked

  • Pharmacy education (meeting reports)

    28 NOV 2008 16:52

    The impact of the White Paper’s recommendations for pharmacy educationin England formed the core of a recent joint one day symposium held bythe Academy of Pharmaceutical Sciences and the Royal PharmaceuticalSociety. Chris Cairns reports

  • White Paper event ranges far and wide

    28 NOV 2008 15:53

    An interactive day explored how key proposals in the Pharmacy White Paper can be turned into local actions. Leila Taheri reports 

  • Antibiotic resistance and usage: a global problem that all must tackle

    28 NOV 2008 15:41

    Who should take responsibility for ensuring antibiotics are correctly used, and how can we educate users and prescribers? Nicola Cree reports 

  • Consultation has opened for the POM to P switch of tamsulosin

    Consultation opens on tamsulosin POM to P switch

    28 NOV 2008 15:15

    Consultation has opened to reclassify the alpha-adrenoceptor antagonist tamsulosin from a prescription-only to a pharmacy medicine.

  • Being told what a medicine is for is patients' top priority

    28 NOV 2008 15:07

    Being told what a medicine is for is the top priority for patients when being prescribed a medicine. This was one of the findings of research published by the Scottish Government earlier this week (26 November 2008).

  • Planning the pharmacy workforce: who are the happy pharmacists? Subscription

    28 NOV 2008 14:45

    In the third of five articles on the Royal Pharmaceutical Society’s pharmacy workforce survey, David Guest, Ali Budjanovcanin and Patricia Oakley examine the various factors that affect job satisfaction and commitment among pharmacists 

  • Changes are not innovations but replacements in operational behaviour (Tbel/

    The reforms of pharmacy in England are novations and replacements Subscription

    27 NOV 2008 17:50

    Over the years, the Government has pledged to reform the operation of community pharmacies in England. Darrin Baines looks at how some of these changes may not be innovations for community pharmacies, but rather novations or replacements, based on the existing model of practice 

  • Oral drug as effective as IV chemotherapy

    27 NOV 2008 17:13

    AstraZeneca’s anticancer drug gefitinib (Iressa) is as effective as intravenous chemotherapy (docetaxel) at improving overall survival in non-small-cell lung cancer (NSCLC) patients, phase III trial results show (Lancet 2008;372:1809).

  • HIV drugs approved for use in NHS Wales

    27 NOV 2008 17:08

    Two HIV medicines are among the drugs approved for use on the NHS in Wales in November 2008.

  • MURs increase 50 per cent

    27 NOV 2008 16:52

    The number of medicines use reviews conducted by community pharmacists in England and Wales in 2007–08 increased by almost 50 per cent from the previous year, according to the NHS information centre.

  • Many unaware of having HIV

    27 NOV 2008 16:50

    An estimated 77,400 people were living with HIV in the UK in 2007 with 28 per cent unaware of their infection, according to Health Protection Agency figures. This compares with a previous estimation of 73,000 for 2006.

  • Stroke and CHD death rates fall

    27 NOV 2008 16:43

    Death rates from stroke and coronary heart disease fell in Scotland during 2007, according to NHS statistics.

  • New UKCPA group will recognise the potential of community pharmacists’ clinical roles

    27 NOV 2008 16:24

    Community pharmacists are to be better recognised for their clinical roles with the inception of a community pharmacy group within the United Kingdom Clinical Pharmacy Association, it was revealed at the association’s autumn residential symposium held in Hinckley, Leicestershire, in November 2008.

  • /files/rps-pjonline/ALERT 3_0_2

    Drug alert: Priadel 400mg prolonged release tablets

    27 NOV 2008 16:18

    An error in the packaging of Priadel 400mg prolonged release tablets distributed since 29 October 2008 has been identified by Sanofi-aventis.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.